We're actively advancing our own clinical research to better understand and support patients undergoing assisted reproduction. Our most recent Institutional Review Board (IRB) approvals focus on:
This study is designed to explore how BSPs can safely and effectively be used as an intrauterine adjunct to help improve endometrial receptivity and implantation potential for women facing persistent challenges with assisted reproductive treatments. It represents an important step toward building our own body of evidence to complement existing peer-reviewed research and demonstrate the real-world impact of our work.
Status: IRB Approved
This next phase expands our research into the potential of BSPs for ovarian rejuvenation, aiming to explore safety, feasibility, and early biological and clinical signals in women with DOR—another population facing critical unmet needs in assisted reproduction.
Status: IRB Approved
We're pleased to share that the IRB for the RIF study has been approved, marking a significant milestone in our clinical research program. In addition, we've just received approval for the DOR study, expanding our research into the potential of BSPs for ovarian rejuvenation—another population facing critical unmet needs in assisted reproduction.
This section compiles key scientific studies and published papers that investigate the role of extracellular vesicles, including exosomes and other nanoscale particles, in fertility and reproductive outcomes. Each article is presented with a clear summary of its purpose, methodology, and results.
Beneath each study, key findings and concise notes are provided to highlight the most important takeaways. These notes are intended to support understanding of the research and provide helpful context for interpreting the results.
Together, these curated studies offer an organized, evidence-based foundation for understanding how extracellular vesicles may influence fertility, embryo development, and reproductive health.